Standout Papers

Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg 2024 202675
  1. Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg (2024)
    Dritan Bejko, Anne Vergison et al. Eurosurveillance

Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 22

Citing Papers

Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain)
2024 Standout
Health effects associated with exposure to secondhand smoke: a Burden of Proof study
2024 Standout
3 intermediate papers

Works of Anne Vergison being referenced

The Burden of Childhood Pneumonia in the Developed World
2012
Impact of Pneumococcal Conjugate Vaccination on Otitis Media: A Systematic Review
2012
and 2 more

Author Peers

Author Last Decade Papers Cites
Anne Vergison 853 859 340 381 46 2.0k
William J. Rodriguez 1088 1259 202 342 58 2.4k
Mathie Lorrot 950 800 161 330 122 2.8k
Salih Hoşoğlu 771 690 369 101 87 2.4k
Kylie Carville 1012 440 110 203 49 2.3k
Edward A. Mortimer 868 650 452 242 95 2.3k
Hannu Sarkkinen 983 684 144 271 64 1.8k
Richard B. Pyles 1299 509 625 234 91 2.8k
Margaret A. K. Ryan 673 951 95 198 53 1.9k
P. Halonen 1691 766 189 382 94 2.7k
Samantha Bosis 1620 723 340 383 84 2.3k

All Works

Loading papers...

Rankless by CCL
2026